Overview

The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia

Status:
Completed

Trial end date:
2020-03-16

Target enrollment:

Participant gender:

Summary

To investigate effects on combination use of Ramelteon in the dose reduction or interruption process of (non-)BZD hypnotics during the dose reduction or interruption algorithm.

Phase:

Phase 4

Details

Lead Sponsor:

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Collaborator:

Yoyogi Sleep Disorder Clinic, Foundation of Sleep and Health Science

Treatments:

Hypnotics and Sedatives
Melatonin